These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 12132500)

  • 21. An evaluation of the economic costs and patient-related consequences of treatments for benign prostatic hyperplasia.
    DiSantostefano RL; Biddle AK; Lavelle JP
    BJU Int; 2006 May; 97(5):1007-16. PubMed ID: 16542339
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Breakthrough treatment for prostate enlargement.
    Johns Hopkins Med Lett Health After 50; 2003 Apr; 15(2):3, 7. PubMed ID: 12712965
    [No Abstract]   [Full Text] [Related]  

  • 23. A current review of medical therapy for benign prostatic hyperplasia.
    Brown GA; Sussman DO
    J Am Osteopath Assoc; 2004 Feb; 104(2 Suppl 2):S11-6. PubMed ID: 15038398
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of standard transurethral resection, transurethral vapour resection and holmium laser enucleation of the prostate for managing benign prostatic hyperplasia of >40 g.
    Gupta N; Sivaramakrishna ; Kumar R; Dogra PN; Seth A
    BJU Int; 2006 Jan; 97(1):85-9. PubMed ID: 16336334
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Benign prostatic obstruction and parkinson's disease--should transurethral resection of the prostate be avoided?
    Roth B; Studer UE; Fowler CJ; Kessler TM
    J Urol; 2009 May; 181(5):2209-13. PubMed ID: 19296974
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Enlarging the scope of managing benign prostatic hyperplasia: addressing sexual function and quality of life.
    Martin DJ; Mulhall JP
    Int J Clin Pract; 2005 May; 59(5):579-90. PubMed ID: 15857355
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Efficacy of high-energy transurethral microwave thermotherapy in alleviating medically refractory urinary retention due to benign prostatic hyperplasia.
    Kellner DS; Armenakas NA; Brodherson M; Heyman J; Fracchia JA
    Urology; 2004 Oct; 64(4):703-6. PubMed ID: 15491705
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A review of the clinical efficacy and safety of 5alpha-reductase inhibitors for the enlarged prostate.
    Naslund MJ; Miner M
    Clin Ther; 2007 Jan; 29(1):17-25. PubMed ID: 17379044
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Photoselective vaporization of the prostate: a volume reduction analysis in patients with lower urinary tract symptoms secondary to benign prostatic hyperplasia and carcinoma of the prostate.
    Kumar SM
    J Urol; 2005 Feb; 173(2):511-3. PubMed ID: 15643231
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Lower urinary tract symptoms (LUTS) and sexual dysfunction (SD): new targets for new combination therapies?
    Sciarra A
    Eur Urol; 2007 Jun; 51(6):1485-7. PubMed ID: 17275984
    [No Abstract]   [Full Text] [Related]  

  • 31. Clinical features and management of benign prostatic hyperplasia.
    Lane T; Shah J
    Hosp Med; 1999 Oct; 60(10):705-9. PubMed ID: 10656061
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Benign prostatic hyperplasia and its treatment.
    Stimson JB; Fihn SD
    J Gen Intern Med; 1990; 5(2):153-65. PubMed ID: 1690275
    [No Abstract]   [Full Text] [Related]  

  • 33. Management of lower urinary tract symptoms suggestive of benign prostatic hyperplasia: the central role of the patient risk profile.
    Crawford ED
    BJU Int; 2005 Jun; 95 Suppl 4():1-5. PubMed ID: 15871729
    [No Abstract]   [Full Text] [Related]  

  • 34. [The objective of medical treatment: relieve the symptoms or stop the course?].
    Desgrandchamps F
    Ann Urol (Paris); 2006 Mar; 40 Spec No 1():14-6. PubMed ID: 16649585
    [No Abstract]   [Full Text] [Related]  

  • 35. [Dalphaz-retard treatment of urination disorders in men and women].
    Loran OB; Pushkar' DIu; Rasner PI
    Urologiia; 2001; (4):47-8. PubMed ID: 11569237
    [No Abstract]   [Full Text] [Related]  

  • 36. [Generally effective for unstable bladder? Tamsulosin: application not limited to benign prostatic hyperplasia].
    Urologe A; 2003 Feb; 42(2):301-2. PubMed ID: 12739514
    [No Abstract]   [Full Text] [Related]  

  • 37. [Therapeutic effect of harnal and proscar in treating benign prostatic hyperplasia].
    Tang ZY; Peng KL; Ding J; Zu XB; Qi L
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2005 Dec; 30(6):708-10. PubMed ID: 16708816
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Etiology of nocturia and clinical efficacy of naftopidil on nocturia in patients with benign prostatic hyperplasia--analysis of frequency volume charts].
    Masuda M; Nakayama K; Hiromoto Y; Hirokawa M; Satomi Y; Shiramizu M; Furuhata A; Ikeda A; Kawasaki C
    Hinyokika Kiyo; 2004 May; 50(5):309-14. PubMed ID: 15237482
    [TBL] [Abstract][Full Text] [Related]  

  • 39. New laser treatments ease severe BPH symptoms.
    Johns Hopkins Med Lett Health After 50; 2006 Dec; 18(10):6. PubMed ID: 17290529
    [No Abstract]   [Full Text] [Related]  

  • 40. Treatment of lower urinary tract symptoms in benign prostatic hyperplasia and its impact on sexual function.
    Miner M; Rosenberg MT; Perelman MA
    Clin Ther; 2006 Jan; 28(1):13-25. PubMed ID: 16490576
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.